Live Updates > Live Update Details
2026-07-18 21:58:13
On July 17, Yangtze River Pharmaceutical Group officially announced the market launch of its independently developed Class 1 innovative drug, Fazanolesen tablets. Related research data indicates that this DORA-type sleep aid has a peak duration of approximately 0.63 to 1.25 hours and a half-life of about 2 to 4 hours. It exhibits pharmacokinetic characteristics such as no significant accumulation after continuous use, rapid onset of action and absorption, and rapid metabolic clearance. This provides solid pharmacological support for the need to simultaneously improve nighttime sleep quality and reduce residual drowsiness the following day.
